FDA will OK updated COVID vaccines for some
Digest more
The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning applies to males ages 16 to 25 and is based on new data from FDA safety monitoring and a 2023 study. This includes both Pfizer's Comirnaty and Moderna's Spikevax vaccines.
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter.
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy
Explore more